Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Shripad Banavali"'
Autor:
Sudeep Gupta, Pankaj Chaturvedi, Vikas Ostwal, Anant Ramaswamy, Supriya Chopra, Vedang Murthy, Kumar Prabhash, Shripad Banavali, Vanita Noronha, Vijay Patil, Jai Prakash Agarwal, Rajendra Badwe, Sudhir Nair, JIGEESHU DIVATIA, Vikram Gota, Nandini Menon, Manali Kolkur, Zoya Peelay, Minit Shah, Vijayalakshmi Mathrudev, Srushti Shah, Kavita Nawale, Nita S Nair, Sarbani Ghosh-Laskar, Sheila N Myatra, Vikram Chaudhari, Sabita Jiwnani, Shailesh V Shrikhande, Richa Vaish, Devendra Chaukar, Shivakumar Thiagarajan, Anil D'Cruz, Amey Oak, Rohini Hawaladar, Oindrila Roy Chowdhury
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective Older patients with cancer have traditionally been under-represented in global clinical trials. There are no data from India regarding this issue.Methods and analysis This was a retrospective analysis done at our institute on interventional
Externí odkaz:
https://doaj.org/article/f74073ec18664ae1a28b2d60b9766297
Autor:
Arshiya Sehgal, Vanita Noronha, Anant Ramaswamy, Anita Kumar, Anupa Pillai, Abhijith Rao, Sharath Kumar, Shreya Gattani, Renita Castelino, Ratan Dhekale, Sarika Mahajan, Anuradha Daptardar, Nabila Ansari, Manjusha Vagal, Lekhika Sonkusare, Purabi Mahajan, Washim Saahil, Pravin Jagtap, Vinod Tripathi, Sunita Satamkar, Manjunath Nookala, Vikram Gota, Shripad Banavali, Rajendra Badwe, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 7, Iss 1, Pp 45-54 (2024)
Background: Older adults often have chronic diseases for which they receive multiple drugs, which may be potentially inappropriate. Objectives: We aimed to describe the potentially inappropriate medications (PIMs) leading to adverse drug events (ADEs
Externí odkaz:
https://doaj.org/article/bb2c1ff2cafe4a3480f375b1ebd618e9
Autor:
Jyoti Bajpai, Pritesh Munot, Kishore Kota, Gaurav Gupta, Kunal Gala, Aashish Gulia, Bharat Rekhi, Nehal Khanna, Nitin Shetty, Prabhat Bhargava, Sujay Srinivas, Vikas Ostwal, Vijay Patil, Vanita Noronha, Suyash Kulkarni, Siddharth Laskar, Kumar Prabhash, Girish Chinnaswamy, Sudeep Gupta, Shripad Banavali
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEDesmoid fibromatosis (DF) is a locally aggressive tumor with low mortality but significant morbidity. There is a lack of standard of care, and existing therapies are associated with significant barriers including access, cost, and toxicities.
Externí odkaz:
https://doaj.org/article/e663551116054eeeb3fdb267afced725
Autor:
Sudivya Sharma, Chetan Dhamne, Shilpushp Bhosale, Badira Parambil, Jigeeshu Divatia, Girish Chinnaswamy, Vasundhara Patil, Rishikesh Joshi, Sridhar Epari, Anita Mahadevan, Sunil Vaidya, Shilpa Kulkarni, Atul Kulkarni, Vijaya Patil, Shyam Srinivasan, Venkata Rama Mohan Gollamudi, Nirmalya Roy Moulik, Maya Prasad, Gaurav Narula, Shripad Banavali
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSETo share our clinical experience with the diagnosis and management of children with hematolymphoid malignancies presenting with epilepsia partialis continua (EPC) as a sequelae of measles infection.MATERIALS AND METHODSIn December 2022, a seri
Externí odkaz:
https://doaj.org/article/712fe734193b49698ec4c760ce1a8f56
Autor:
Sharath Kumar, Renita Castelino, Abhijith Rao, Shreya Gattani, Anita Kumar, Anupa Pillai, Arshiya Sehgal, Pallavi Rane, Anant Ramaswamy, Ratan Dhekale, Jyoti Krishnamurthy, Shripad Banavali, Rajendra Badwe, Kumar Prabhash, Vanita Noronha, Vikram Gota
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Polypharmacy and potentially inappropriate medication (PIM) use are common problems in older adults. Safe prescription practices are a necessity. The tools employed for the identification of PIM sometimes do not concur with each o
Externí odkaz:
https://doaj.org/article/ea58735ef4744015b16ebc2a5ac8bd6e
Autor:
Abhijith R Rao, Vanita Noronha, Anant Ramaswamy, Anita Kumar, Anupa Pillai, Arshiya Sehgal, Sharath Kumar, Shreya C Gattani, Renita Castelino, Ratan Dhekale, Sarika G Mahajan, Anuradha A Daptardar, Nabila Ansari, Manjusha Vagal, Lekhika Sonkusare, Jayita K Deodhar, Purabi Mahajan, Shivshankar Timmanpyati, Vikram Gota, Shripad Banavali, Rajendra A Badwe, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 3, Pp 408-417 (2023)
Background: Frailty is a significant concern in older patients with cancer, yet there are limited data on frailty and its associated risk factors, particularly in Indian patients. Objectives: The primary objective was to evaluate the occurrence of fr
Externí odkaz:
https://doaj.org/article/5b8e60a54aed4e83aedf6b7975cabaef
Autor:
Prashant Tembhare, Simpy Raj, Sitaram Ghogale, Nilesh Deshpande, Karishma Girase, Gaurav Chatterjee, Sweta Rajpal, Nikhil Patkar, Gaurav Narula, Bhausaheb Bagal, Hasmukh Jain, Manju Sengar, Shripad Banavali, Dhanlaxmi Shetty, Chetan Dhamne, Twinkle Khanka, Steffi Varghese, Shaista Jasdanwala, Navin Khattry, Papagudi G Subramanian, Sumeet Gujral
Publikováno v:
HemaSphere, Vol 7, p e94316c1 (2023)
Externí odkaz:
https://doaj.org/article/63aa046789ea4a1b80fdff80165dfc88
Autor:
Vanita Noronha, Abhijith Rao, Shreya Gattani, Anant Ramaswamy, Anita Kumar, Sharath Kumar, Renita Castelino, Ratan Dhekale, Jyoti Krishnamurthy, Akash Pawar, Sarika Mahajan, Anuradha Daptardar, Lekhika Sonsukare, Jayita Deodhar, Nabila Ansari, Manjusha Vagal, Vikram Gota, Shripad Banavali, Kumar Prabhash, Rajendra Badwe
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 5, Iss 4, Pp 673-680 (2022)
Background: The geriatric assessment is a multidimensional evaluation of an older person. Globally, it is reported that geriatric assessments can lead to a change in the oncologic therapy decisions in approximately 28% of patients, but there are no I
Externí odkaz:
https://doaj.org/article/cc6ce0678d404ed09d49fbfbdbae03ae
Autor:
Nandana Das, Shripad Banavali, Sameer Bakhshi, Amita Trehan, Venkatraman Radhakrishnan, Rachna Seth, Brijesh Arora, Gaurav Narula, Subir Sinha, Prakriti Roy, Manash Pratim Gogoi, Sayan Chatterjee, Bindhu Abraham, Parag Das, Vaskar Saha, Shekhar Krishnan
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-20 (2022)
Abstract Background In the west, survival following treatment of childhood acute lymphoblastic leukaemia (ALL) approaches 90%. Outcomes in India do not exceed 70%. To address this disparity, the Indian Collaborative Childhood Leukaemia group (ICiCLe)
Externí odkaz:
https://doaj.org/article/eb1369a80be34976944007a96161b1e7
Autor:
Vijay M. Patil, Nandini Menon, Abhishek Chatterjee, Raees Tonse, Amit Choudhari, Abhishek Mahajan, Ameya D. Puranik, Sridhar Epari, Monica Jadhav, Shruti Pathak, Zoya Peelay, Rutuja Walavalkar, Hemanth K. Muthuluri, Madala Ravi Krishna, Arun Chandrasekharan, Nikhil Pande, Tejpal Gupta, Shripad Banavali, Rakesh Jalali
Publikováno v:
EClinicalMedicine, Vol 49, Iss , Pp 101449- (2022)
Summary: Background: Recurrent glioblastoma (GBM) has dismal outcomes and limited treatment options. Mebendazole (MBZ) has activity in glioma both in-vivo and in-vitro, and is well tolerated in combination with lomustine (CCNU) and temozolomide (TMZ)
Externí odkaz:
https://doaj.org/article/e4971882039442a38189da5c4a093f24